Wesfarmers Ltd (ASX: WES) is emerging as a strong candidate for investors looking to maintain their portfolio's momentum amid market volatility. The company's shares were trading around $76.39 on Friday, significantly below their 52-week high of $93.25, presenting a potential opportunity for investors.
The company's retail divisions, particularly Kmart and Bunnings, are well-positioned to thrive in a challenging economic environment. With the Reserve Bank of Australia raising interest rates to 4.85% and unemployment rising to 4.9%, consumers are becoming more price-conscious. Kmart's focus on affordable essentials and Bunnings' competitive home improvement offerings make them resilient choices. Both divisions reported earnings growth in FY26, with Bunnings generating $2.46 billion (up 5.1%) and Kmart Group delivering $1.11 billion (up 6%), despite price reductions on thousands of products.
Beyond retail, Wesfarmers has diversified operations in chemicals, fertilisers, lithium, and healthcare. The chemicals, energy, and fertilisers division saw an 18.5% increase in earnings to $473 million, while Wesfarmers Health achieved nearly $6.5 billion in revenue, though with modest earnings of $76 million. This diversification provides additional growth avenues, though challenges remain in areas like Officeworks profitability and lithium market uncertainty.
Analysts expect Wesfarmers to generate earnings per share (EPS) of $2.66 in FY27, rising to $2.89 in FY28 and $3.06 in FY29. At $76.39, the shares trade on a price-to-earnings (PE) ratio of approximately 28.7 times forecast FY27 earnings, above its 10-year average of 26.4 times. While not cheap, the company's strong business fundamentals and growth potential justify the valuation for long-term investors.